Surgical treatment of primary small-cell esophageal carcinoma / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
;
(6): 329-331, 2006.
Article
in Chinese
| WPRIM
| ID: wpr-281205
ABSTRACT
<p><b>OBJECTIVE</b>To explore the surgical treatment of primary small-cell esophageal carcinoma (PSEC).</p><p><b>METHODS</b>We retrospectively analyzed the clinical data of 73 patients with PSEC who received surgical treatment in our hospital from 1984 to 2003.</p><p><b>RESULTS</b>The overall resection rate was 94.5%. The complete resection rate was 89.0% and operation mortality was 1.4%. The 1-year, 3-year, and 5-year survival were 50.7%, 13.7%, and 8.2%, respectively.</p><p><b>CONCLUSIONS</b>PSEC is a rare malignant tumor with poor prognosis. Surgical resection is the main method for patients in stage I or II, and postoperative chemotherapy seems to be helpful. Patients in stage Ill or IV should be managed with chemotherapy and radiotherapy.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Prognosis
/
General Surgery
/
Esophageal Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Survival Rate
/
Retrospective Studies
/
Mortality
/
Carcinoma, Small Cell
/
Combined Modality Therapy
/
Therapeutic Uses
Type of study:
Observational study
/
Prognostic study
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
Chinese
Journal:
Acta Academiae Medicinae Sinicae
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS